These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30858029)

  • 1. Role of the endocannabinoid system in neurological disorders.
    Zou M; Li D; Li L; Wu L; Sun C
    Int J Dev Neurosci; 2019 Aug; 76():95-102. PubMed ID: 30858029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the endocannabinoid system and its therapeutic potential in autism spectrum disorder.
    Zou M; Liu Y; Xie S; Wang L; Li D; Li L; Wang F; Zhang Y; Xia W; Sun C; Wu L
    Open Biol; 2021 Feb; 11(2):200306. PubMed ID: 33529552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models.
    Zamberletti E; Gabaglio M; Parolaro D
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28880200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.
    Fyke W; Alarcon JM; Velinov M; Chadman KK
    Autism Res; 2021 Jul; 14(7):1375-1389. PubMed ID: 33886158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on the Role of Endocannabinoids in Autism Spectrum Disorders.
    Yeh ML; Levine ES
    OBM Neurobiol; 2017; 1(2):. PubMed ID: 30854511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid Signaling in Autism.
    Chakrabarti B; Persico A; Battista N; Maccarrone M
    Neurotherapeutics; 2015 Oct; 12(4):837-47. PubMed ID: 26216231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
    Schultz S; Gould GG; Antonucci N; Brigida AL; Siniscalco D
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence.
    Colizzi M; Bortoletto R; Costa R; Zoccante L
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33919499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids, exercise, pain, and a path to health with aging.
    Watkins BA
    Mol Aspects Med; 2018 Dec; 64():68-78. PubMed ID: 30290200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-Based Molecules on Signaling Pathways in Autism Spectrum Disorder.
    Yui K; Imataka G; Yoshihara S
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the Endocannabinoid System: Exploring Its Therapeutic Potential in Autism Spectrum Disorder.
    Jana A; Nath A; Sen P; Kundu S; Alghamdi BS; Abujamel TS; Saboor M; Woon-Khiong C; Alexiou A; Papadakis M; Alam MZ; Ashraf GM
    Neuromolecular Med; 2024 May; 26(1):20. PubMed ID: 38744725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights on endocannabinoid transmission in psychomotor disorders.
    Giuffrida A; Seillier A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):51-8. PubMed ID: 22521335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders.
    de Oliveira RW; Oliveira CL; Guimarães FS; Campos AC
    Acta Neuropsychiatr; 2019 Feb; 31(1):1-16. PubMed ID: 29764526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
    Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
    Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis.
    Oudin MJ; Hobbs C; Doherty P
    Eur J Neurosci; 2011 Nov; 34(10):1634-46. PubMed ID: 22103420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk.
    Kumar S; Reynolds K; Ji Y; Gu R; Rai S; Zhou CJ
    J Neurodev Disord; 2019 Jun; 11(1):10. PubMed ID: 31202261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.
    Brigida AL; Schultz S; Cascone M; Antonucci N; Siniscalco D
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.
    van der Stelt M; Di Marzo V
    Eur J Pharmacol; 2003 Nov; 480(1-3):133-50. PubMed ID: 14623357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
    Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
    Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocannabinoid-mediated synaptic plasticity in the CNS.
    Chevaleyre V; Takahashi KA; Castillo PE
    Annu Rev Neurosci; 2006; 29():37-76. PubMed ID: 16776579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.